HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Matsui Selected Research

2- (4- bromophenyl)- 6- methyl- N- (2- (1- oxidopyridin- 3- yl)ethyl)pyrimidin- 4- amine

1/2011The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic β-cell function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Matsui Research Topics

Disease

12Infections
10/2009 - 02/2000
11Alzheimer Disease (Alzheimer's Disease)
01/2007 - 01/2000
9Neoplasms (Cancer)
08/2017 - 09/2000
9Diabetic Nephropathies (Diabetic Nephropathy)
09/2016 - 01/2007
9Atherosclerosis
08/2011 - 09/2001
8Insulin Resistance
12/2008 - 01/2005
8Rheumatoid Arthritis
01/2007 - 03/2000
7Inflammation (Inflammations)
01/2018 - 03/2000
6Hypertension (High Blood Pressure)
05/2016 - 01/2005
5Neoplasm Metastasis (Metastasis)
01/2014 - 04/2001
5Diabetic Retinopathy (Retinopathy, Diabetic)
01/2006 - 01/2005
4Thrombosis (Thrombus)
01/2017 - 03/2000
4Vascular System Injuries
01/2016 - 12/2006
4Leukemia
08/2013 - 08/2000
4Hypoxia (Hypoxemia)
04/2010 - 09/2000
4Hepatocellular Carcinoma (Hepatoma)
09/2008 - 12/2006
4Cognitive Dysfunction
01/2007 - 11/2000
4Heart Failure
12/2001 - 01/2000
3Stomach Neoplasms (Stomach Cancer)
11/2019 - 11/2009
3Fibrosis (Cirrhosis)
01/2018 - 04/2001
3Necrosis
01/2017 - 11/2006
3Wounds and Injuries (Trauma)
05/2016 - 11/2001
3Hyperglycemia
08/2015 - 01/2005
3Type 2 Diabetes Mellitus (MODY)
01/2011 - 01/2006
3Carcinoma (Carcinomatosis)
11/2009 - 06/2000
3Cardiovascular Diseases (Cardiovascular Disease)
08/2008 - 01/2005
3Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2007 - 01/2006
3Chronic Kidney Failure (Chronic Renal Failure)
01/2007 - 10/2001
3Diabetic Angiopathies (Diabetic Angiopathy)
01/2007 - 01/2005
3Hemorrhage
10/2006 - 08/2000
3Diabetes Mellitus
01/2006 - 01/2006
3Myocardial Ischemia (Ischemic Heart Diseases)
10/2005 - 01/2001
3Colorectal Neoplasms (Colorectal Cancer)
03/2003 - 06/2000
3Hypertrophy
04/2001 - 01/2000
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2001 - 01/2001
3Hemolysis
08/2000 - 01/2000
2Colonic Neoplasms (Colon Cancer)
11/2021 - 01/2016
2Alcoholic Fatty Liver
01/2018 - 01/2006
2Crohn Disease (Crohn's Disease)
11/2017 - 07/2001
2Body Weight (Weight, Body)
11/2017 - 04/2015
2Hypothermia
09/2017 - 02/2004
2Tuberculosis (Tuberculoses)
01/2017 - 10/2000
2Albuminuria
08/2015 - 09/2014
2Extramammary Paget Disease (Paget Disease, Extramammary)
07/2014 - 01/2014
2Lymphatic Metastasis
07/2014 - 01/2014
2Melanoma (Melanoma, Malignant)
05/2013 - 01/2007
2Ulcerative Colitis
02/2013 - 09/2006
2Fever (Fevers)
07/2009 - 02/2000
2Dermatitis
10/2008 - 08/2004
2Hypersensitivity (Allergy)
10/2008 - 09/2000

Drug/Important Bio-Agent (IBA)

23Advanced Glycation End ProductsIBA
03/2016 - 01/2005
16Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2000
8AntigensIBA
01/2017 - 09/2000
7AntibodiesIBA
11/2017 - 08/2000
6Insulin (Novolin)FDA Link
04/2015 - 01/2005
6pigment epithelium-derived factorIBA
03/2009 - 01/2005
6CalciumIBA
11/2007 - 01/2000
5Messenger RNA (mRNA)IBA
01/2018 - 06/2000
5Immunoglobulin E (IgE)IBA
09/2017 - 09/2000
5Anti-Bacterial Agents (Antibiotics)IBA
10/2009 - 02/2000
5AutoantibodiesIBA
07/2001 - 01/2001
4LipidsIBA
01/2018 - 01/2006
4CholesterolIBA
01/2018 - 12/2001
4Glucose (Dextrose)FDA LinkGeneric
03/2016 - 01/2011
4Telmisartan (Micardis)FDA Link
09/2008 - 12/2006
4PPAR gammaIBA
09/2008 - 12/2006
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2007 - 07/2001
4Immunoglobulin G (IgG)IBA
06/2001 - 08/2000
3CytokinesIBA
01/2017 - 02/2004
3Peptides (Polypeptides)IBA
09/2016 - 04/2001
38-Hydroxy-2'-DeoxyguanosineIBA
08/2015 - 09/2014
3FructoseIBA
04/2015 - 01/2005
3SteroidsIBA
02/2013 - 08/2000
3Reactive Oxygen Species (Oxygen Radicals)IBA
11/2007 - 03/2001
31,4-dihydropyridine (dihydropyridine)IBA
11/2007 - 11/2006
3Nifedipine (Adalat)FDA LinkGeneric
11/2007 - 01/2007
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
11/2007 - 09/2006
3YM 529IBA
01/2007 - 01/2005
3C-Reactive ProteinIBA
01/2007 - 07/2001
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2006 - 01/2006
3Biomarkers (Surrogate Marker)IBA
01/2002 - 04/2001
3Monoclonal AntibodiesIBA
07/2001 - 06/2000
3Hemoglobins (Hemoglobin)IBA
08/2000 - 01/2000
2Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2021 - 01/2016
2Pharmaceutical PreparationsIBA
11/2017 - 05/2005
2InterferonsIBA
01/2017 - 10/2005
2Ointments (Pastes)IBA
05/2016 - 08/2011
2Metformin (Glucophage)FDA LinkGeneric
05/2013 - 11/2012
2Tacrolimus (Prograf)FDA LinkGeneric
02/2013 - 09/2006
2DNA (Deoxyribonucleic Acid)IBA
08/2011 - 10/2000
2Protein Isoforms (Isoforms)IBA
04/2010 - 02/2001
2Atorvastatin (Lipitor)FDA Link
11/2008 - 01/2007

Therapy/Procedure

13Therapeutics
04/2010 - 08/2000
4Oral Administration
09/2006 - 03/2000
3Blood Transfusion (Blood Transfusions)
04/2001 - 08/2000
2Adjuvant Chemotherapy
11/2021 - 11/2001
2Gastrectomy
11/2019 - 11/2009
2Neoadjuvant Therapy
08/2017 - 11/2001
2Radiotherapy
07/2014 - 01/2014
2Drug Therapy (Chemotherapy)
11/2009 - 01/2000